— Know what they know.
Not Investment Advice
Also trades as: 1530.HK (HKSE) · $vol 61M

TRSBF OTC

3SBio Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -39.6% 1Y: -38.6% 3Y: +182.7% 5Y: +196.8%
$2.15
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 48 · $5.4B mcap · 1.93B float · 0.0000% daily turnover · Short 100% of daily vol

Cash Flow Trends

Operating Cash Flow
$3.2B +53.7% ▲
5Y CAGR: +11.1%
Capital Expenditures
$963M -36.8% ▼
5Y CAGR: +14.7%
Free Cash Flow
$2.2B +62.3% ▲
5Y CAGR: +9.8%
Dividends Paid
$555M -146.8% ▼
Buybacks
$242M +0.0% ▲
Net Change in Cash
-$469M -202.0% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income$979M$1.9B$2.3B$2.0B$2.7B
Depreciation & Amort.$361M$329M$382M$335M$395M
Stock-Based Comp.$101M$30M$11M-$5M$32M
Change in Working Capital-$302M-$332M$70M-$162M$566M
Other Non-Cash Items-$4M-$60M-$557M-$64M-$510M
Operating Cash Flow$1.3B$1.6B$2.2B$2.1B$3.2B
— Investing Activities —
Capital Expenditures-$981M-$1.1B-$911M-$625M-$682M
Acquisitions (Net)-$200M$332M-$47M-$78M-$335M
Investment Purchases-$7.5B-$8.6B-$16.7B-$5.9B-$6.5B
Investment Sales$6.7B$8.0B$13.8B$5.2B$6.0B
Other Investing$148M$154M$201M$74M$192M
Investing Cash Flow-$1.9B-$1.3B-$3.7B-$1.3B-$1.4B
— Financing Activities —
Net Debt Issuance$40M-$109M$1.7B-$3M-$1.3B
Stock Repurchased-$11M-$413M-$476M$0-$242M
Dividends Paid$0$0-$417M-$225M-$555M
Other Financing$1.5B$41M-$44M-$126M-$192M
Financing Cash Flow$1.6B-$481M$763M-$353M-$2.3B
Net Change in Cash$1.0B-$223M-$718M$459M-$469M
Cash End of Period$3.1B$2.9B$2.2B$2.6B$2.1B
Free Cash Flow$363M$433M$1.2B$1.4B$2.2B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms